Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > J. Kenneth Hillan > Profile

J. Kenneth Hillan

Affiliations

  • at Sangamo Therapeutics Inc (SGMO), 2025-06-16
  • at Zymeworks Inc. (ZYME), 2023-12-08
  • Chief Therapeutics Officer at 23Andme Holding Co. (ME), 2023-06-07
  • Director at Zymeworks Inc. (ZYME), 2021-05-07
  • See Remarks at Achaogen Inc (AKAO), 2018-06-30
  • Director at Relypsa Inc (RLYP), 2016-09-02
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ME $3.64 8,753 $31,860.92 196,083 2022-08-24 Filing
AKAO $9.59 744 $7,134.96 115,401 2018-06-26 Filing
AKAO $11.74 2,735 $32,108.90 95,151 2018-03-13 Filing
AKAO $10.67 4,606 $49,146.02 97,886 2018-02-21 Filing
AKAO $26.58 3,079 $81,839.82 98,422 2017-03-14 Filing